Xcell-center

XCell-Center GmbH Gets Approval by French Health Authorities to Conduct Clinical Trial with Stem Cells for Chronic Spinal Cord Injury

Older News

DUSSELDORF, Germany, June 7, 2010 - XCell-Center GmbH, Europe's leading provider of adult autologous stem cell therapy, announced approval of the first placebo controlled double blind clinical trial in patients with chronic spinal cord injury.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy